However, this is probably not a real effect of metformin on adiponectin levels but can be explained by the fact that this oral hypoglycemic agent is contraindicated in patients with advanced kidney disease due to the risk for lactic acidosis. The gene discussed is ADIPOQ; the disease is lactic acidosis.